4//SEC Filing
Garabedian Christopher Nishan 4
Accession 0001209191-22-030044
CIK 0001785345other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:28 PM ET
Size
5.4 KB
Accession
0001209191-22-030044
Insider Transaction Report
Form 4
Garabedian Christopher Nishan
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-16+18,000→ 18,000 totalExercise: $0.64Exp: 2032-05-15→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to this option will vest and become exercisable in equal monthly installments commencing May 19, 2022, subject to the Reporting Person providing continuous service to the Issuer.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001843665
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:28 PM ET
- Size
- 5.4 KB